Cambridge, MANCT01733082Now EnrollingIRB Ready

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases Clinical Trial in Cambridge, MA

Access cutting-edge heart transplantation, kidney transplantation, liver transplantation, autoimmune diseases treatment through this clinical trial at a research site in Cambridge. Study-provided care at no cost to qualified participants.

Sponsored by Genentech, Inc.

Quick Self-Assessment

See if you qualify for this Cambridge location

Preparing your pre-screening questions…

Expert Care in Cambridge

Access heart transplantation, kidney transplantation, liver transplantation, autoimmune diseases specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related heart transplantation, kidney transplantation, liver transplantation, autoimmune diseases treatment provided free

Apply for This Cambridge Location

Check if you qualify for this heart transplantation, kidney transplantation, liver transplantation, autoimmune diseases clinical trial in Cambridge, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cambridge

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cambridge site if eligible
  4. 4Begin participation

About This Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases Study in Cambridge

The Mycophenolate Pregnancy Registry is designed as a prospective, observational registry collecting data regarding mycophenolate exposure during pregnancy, and pregnancy outcomes, fetal and infant outcomes after exposure. Early and later term pregnancy outcomes will be solicited at selected gestational time points. Structural and functional birth defects identified in the perinatal period through one year of life will be collected and classified. This is a non-proprietary registry and is a component of a comprehensive pregnancy Risk Evaluation and Mitigation Strategy (REMS) plan required by the FDA for all mycophenolate-formulations, including CellCept, Myfortic and any generic formulations.

Sponsor: Genentech, Inc.

Who Can Participate

Inclusion Criteria

Pregnancy and reported maternal exposure to mycophenolate during pregnancy or within 6 weeks of discontinuing treatment

Exclusion Criteria

Pregnancies for which there is paternal exposure only
Pregnancies occurring outside the U.S.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cambridge?

Yes, this clinical trial (NCT01733082) has an active research site in Cambridge, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases Treatment Options in Cambridge, MA

If you're searching for heart transplantation, kidney transplantation, liver transplantation, autoimmune diseases treatment options in Cambridge, MA, this clinical trial (NCT01733082) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cambridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart transplantation, kidney transplantation, liver transplantation, autoimmune diseases specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all heart transplantation, kidney transplantation, liver transplantation, autoimmune diseases clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Cambridge, MA

See all multiple myeloma clinical trials recruiting in Cambridge — not just this study.

Browse Multiple Myeloma Trials in Cambridge

Ready to Join in Cambridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cambridge, MA